| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Nautilus Biotechnology, Inc.
13D/A
NAUT · 63909J108
|
16.3% |
3/4/2026
Event 3/2/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.